Related references
Note: Only part of the references are listed.Barriers to and strategies to address COVID-19 testing hesitancy: a rapid scoping review
Mark Embrett et al.
BMC PUBLIC HEALTH (2022)
Estimated Incidence of Coronavirus Disease 2019 (COVID-19) Illness and Hospitalization-United States, February-September 2020
Heather Reese et al.
CLINICAL INFECTIOUS DISEASES (2021)
Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys
Frederick J. Angulo et al.
JAMA NETWORK OPEN (2021)
Defining the Epidemiology of Covid-19-Studies Needed
Marc Lipsitch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR
Yicheng Fang et al.
RADIOLOGY (2020)
Diagnostic Tools for Coronavirus Disease (COVID-19): Comparing CT and RT-PCR Viral Nucleic Acid Testing
Joseph Waller et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2020)
Diagnosis and Management of First Case of COVID-19 in Canada: Lessons Applied From SARS-CoV-1
Xavier Marchand-Senecal et al.
CLINICAL INFECTIOUS DISEASES (2020)
Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?
Chunqin Long et al.
EUROPEAN JOURNAL OF RADIOLOGY (2020)
Changes in testing rates could mask the novel coronavirus disease (COVID-19) growth rate
Ryosuke Omori et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020
Neeraj Sood et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Estimating the burden of SARS-CoV-2 in France
Henrik Salje et al.
SCIENCE (2020)
Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)
Ruiyun Li et al.
SCIENCE (2020)
A Systematic Review of COVID-19 Epidemiology Based on Current Evidence
Minah Park et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York
Eli S. Rosenberg et al.
ANNALS OF EPIDEMIOLOGY (2020)
Understanding heterogeneity to inform the public health response to COVID-19 in Canada
Sharmistha Mishra et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2020)
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020
Fiona P. Havers et al.
JAMA INTERNAL MEDICINE (2020)
Estimated Community Seroprevalence of SARS-CoV-2 Antibodies - Two Georgia Counties, April 28-May 3, 2020
Holly M. Biggs et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample - Indiana, April 25-29, 2020
Nir Menachemi et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Real-time PCR-based SARS-CoV-2 detection in Canadian laboratories
Jason J. LeBlanc et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
Silvia Stringhini et al.
LANCET (2020)
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
Marina Pollan et al.
LANCET (2020)
Substantial underestimation of SARS-CoV-2 infection in the United States
Sean L. Wu et al.
NATURE COMMUNICATIONS (2020)
Measuring underreporting and under-ascertainment in infectious disease datasets: a comparison of methods
Cheryl L. Gibbons et al.
BMC PUBLIC HEALTH (2014)
Estimates of the Burden of Foodborne Illness in Canada for 30 Specified Pathogens and Unspecified Agents, Circa 2006
M. Kate Thomas et al.
FOODBORNE PATHOGENS AND DISEASE (2013)
The disease pyramid for acute gastrointestinal illness in New Zealand
R. J. Lake et al.
EPIDEMIOLOGY AND INFECTION (2010)
Estimates of the Prevalence of Pandemic (H1N1) 2009, United States, April-July 2009
Carrie Reed et al.
EMERGING INFECTIOUS DISEASES (2009)
Estimating the under-reporting rate for infectious gastrointestinal illness in Ontario
SE Majowicz et al.
CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE (2005)
Share Paper
